Preoperative Methods to Reduce Liver Volume in Bariatric Surgery: a Systematic Review

Obesity Surgery

Volumn 26, Issue 2, 2016, Pages 251-256

  van Wissen, J ^a,b,c   Bakker, N ^a,b,c   Doodeman, H J ^a,c   Jansma, E P ^b   Bonjer, H J ^b   Houdijk, A P J ^a,b,c  

^a Location Alkmaar   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Trial Center Holland Health   (Netherlands)

Author keywords

Bariatric surgery; Laparoscopic Roux en Y gastric bypass; Liver; Liver volume; Preoperative care; Preoperative diets

Indexed keywords

ARTICLE; BARIATRIC SURGERY; COCHRANE LIBRARY; DIET RESTRICTION; EMBASE; ENDOSCOPY; GASTRIC BALLOON; GASTROESOPHAGEAL JUNCTION; HUMAN; LIVER SIZE; LIVER WEIGHT; LOW CALORY DIET; MEDLINE; MORBID OBESITY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; STOMACH BYPASS; SYSTEMATIC REVIEW; CALORIC RESTRICTION; COMPLICATION; DIETARY SUPPLEMENT; FATTY LIVER; GASTRIC BYPASS SURGERY; LIVER; OBESITY, MORBID; ORGAN SIZE; PATHOLOGY; PREOPERATIVE CARE; WEIGHT REDUCTION;

CALORIC RESTRICTION; DIETARY SUPPLEMENTS; FATTY LIVER; GASTRIC BALLOON; GASTRIC BYPASS; HUMANS; LIVER; OBESITY, MORBID; ORGAN SIZE; PREOPERATIVE CARE; WEIGHT LOSS;

EID: 84933574992     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-015-1769-5     Document Type: Article

References (26)

1. Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. Int J Obes. 2005;37(6):889–-91. PubMed Pubmed Central PMCID: Pmc3527647. Epub 2012/09/19. eng.
2. Kissler HJ, Settmacher U. Bariatric surgery to treat obesity. Semin Nephrol. 2013;33(1):75–89. PubMed Epub 2013/02/05. eng.
3. Beymer C, Kowdley KV, Larson A, et al. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch Surg. 2003;138(11):1240–4. PubMed Epub 2003/11/12. eng.
4. Cordeiro L, Campos JM, de Paula PS, et al. Nonalcoholic steatohepatitis on preoperative period of gastric bypass: lack of correlation with degree of obesity. Arq Bras Cir Dig ABCD = Braz Arch Dig Surg. 2013;26 Suppl 1:39–42. PubMed Epub 2014/01/28. eng.
5. Guajardo-Salinas GE, Hilmy A. Prevalence of nonalcoholic fatty liver disease (NAFLD) and utility of FIBROspect II to detect liver fibrosis in morbidly obese Hispano-American patients undergoing gastric bypass. Obes Surg. 2010;20(12):1647–53. PubMed Epub 2009/12/04. eng.
6. Losekann A, Weston AC, Carli LA, et al. Nonalcoholic fatty liver disease in severe obese patients, subjected to bariatric surgery. Arq Gastroenterol. 2013;50(4):285–9. PubMed Epub 2014/01/30. eng.
7. Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006;45(4):600–6. PubMed Epub 2006/08/11. eng.
8. Reha JL, Lee S, Hofmann LJ. Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience. Am Surg. 2014;80(6):595–9. PubMed Epub 2014/06/03. eng.
9. Wu J, You J, Yerian L, et al. Prevalence of liver steatosis and fibrosis and the diagnostic accuracy of ultrasound in bariatric surgery patients. Obes Surg. 2012;22(2):240–7. PubMed Epub 2011/09/09. eng.
10. Schwartz ML, Drew RL, Chazin-Caldie M. Factors determining conversion from laparoscopic to open Roux-en-Y gastric bypass. Obes Surg. 2004;14(9):1193–7. PubMed Epub 2004/11/06. eng.
11. Schwartz ML, Drew RL, Chazin-Caldie M. Laparoscopic Roux-en-Y gastric bypass: preoperative determinants of prolonged operative times, conversion to open gastric bypasses, and postoperative complications. Obes Surg. 2003;13(5):734–-8. PubMed Epub 2003/11/25. eng.
12. Aberle J, Freier A, Busch P, et al. Treatment with sibutramine prior to Roux-en-Y gastric bypass leads to an improvement of metabolic parameters and to a reduction of liver size and operative time. Obes Surg. 2009;19(11):1504–7. PubMed Epub 2009/08/28. eng.
13. Benjaminov O, Beglaibter N, Gindy L, et al. The effect of a low-carbohydrate diet on the nonalcoholic fatty liver in morbidly obese patients before bariatric surgery. Surg Endosc. 2007;21(8):1423–7. PubMed Epub 2007/03/03. eng.
14. Brody F, Vaziri K, Garey C, et al. Preoperative liver reduction utilizing a novel nutritional supplement. J Laparoendosc Adv Surg Tech A. 2011;21(6):491–5. PubMed Epub 2011/04/21. eng.
15. Colles SL, Dixon JB, Marks P, et al. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. The Am J Clin Nut. 2006;84(2):304–11. PubMed Epub 2006/08/10. eng.
16. Collins J, McCloskey C, Titchner R, et al. Preoperative weight loss in high-risk superobese bariatric patients: a computed tomography-based analysis. Surg Obes Related Dis Off J Am Soc Bariatric Surg. 2011;7(4):480–5. PubMed Epub 2010/12/28. eng.
17. Edholm D, Kullberg J, Haenni A, et al. Preoperative 4-week low-calorie diet reduces liver volume and intrahepatic fat, and facilitates laparoscopic gastric bypass in morbidly obese. Obes Surg. 2011;21(3):345–50. PubMed Epub 2010/12/25. eng.
18. Fris RJ. Preoperative low energy diet diminishes liver size. Obes Surg. 2004;14(9):1165–70. PubMed Epub 2004/11/06. eng.
19. Frutos MD, Morales MD, Lujan J, et al. Intragastric balloon reduces liver volume in super-obese patients, facilitating subsequent laparoscopic gastric bypass. Obes Surg. 2007;17(2):150–4. PubMed Epub 2007/05/05. eng.
20. Gonzalez-Perez J, Sanchez-Leenheer S, Delgado AR, et al. Clinical impact of a 6-week preoperative very low calorie diet on body weight and liver size in morbidly obese patients. Obes Surg. 2013;23(10):624–31. PubMed Epub 2013/05/18. eng.
21. Iannelli A, Martini F, Schneck AS, et al. Preoperative 4-week supplementation with omega-3 polyunsaturated fatty acids reduces liver volume and facilitates bariatric surgery in morbidly obese patients. Obes Surg. 2013;23(11):1761–5. PubMed Epub 2013/05/21. eng.
22. Lewis MC, Phillips ML, Slavotinek JP, et al. Change in liver size and fat content after treatment with Optifast very low calorie diet. Obes Surg. 2006;16(6):697–701. PubMed Epub 2006/06/08. eng.
23. Derosa G, Maffioli P. Anti-obesity drugs: a review about their effects and their safety. Expert Opin Drug Saf. 2012;11(3):459–71. PubMed Epub 2012/03/24. eng.
24. Cassie S, Menezes C, Birch DW, et al. Effect of preoperative weight loss in bariatric surgical patients: a systematic review. Surg Obes Relat Dis Off J Am Soc Bariatric Sur. 2011;7(6):760–7. discussion 7. PubMed Epub 2011/10/08. eng.
25. AlShaalan R, Aljiffry M, Al-Busafi S, et al. Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis. Saudi J Gastroenterol Off J Saudi Gastroenterol Assoc. 2015;21(2):64–70. PubMed Epub 2015/04/07. eng.
26. Bril F, Ortiz-Lopez C, Lomonaco R, Orsak B, Freckleton M, Chintapalli K, et al. Clinical Value of Liver Ultrasound for the Diagnosis of Nonalcoholic Fatty Liver Disease in Overweight and Obese Patients. Liver international: official journal of the International Association for the Study of the Liver. 2015 Apr 4. PubMed Epub 2015/04/08. Eng